Medical Technology

@xconomy.com 4 years ago

Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

@xconomy.com 4 years ago

Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone

@xconomy.com 5 years ago

Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More

@xconomy.com 5 years ago

Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel

@xconomy.com 5 years ago

Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More

@xconomy.com 6 years ago

CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”